Text
Industry
Sponsored by
Probiotic intervention in the gut–prostate axis with novaPROX combo: insights from an in vitro study
The study published on Foods Journal researched the mechanisms of action of Probionova's novaPROX product using a 3D intestinal barrier model and a co-culture prostatic model.
On the second anniversary of its launch, Ferring Pharmaceuticals’ REBYOTA remains a landmark innovation in the prevention of recurrent Clostridioides difficile.
The findings of a recent study suggest that while T. musculis can worsen asthma, it might also help the body fight off infections, offering potential for new treatments targeting the…
The skin can independently generate immune responses to control the microbiota and prevent infections, without relying on other immune centers.
Lonza's capsules ensures targeted intestinal delivery enhancing stability and therapeutic efficacy for LBPs and pharmaceutical applications.
Cmbio announces a strategic partnership with Nimble Science to deliver first in class high-quality, multi-omic data insights from the small intestine.
The findings suggest that the microbial communities inhabiting an infant’s nose and throat can play a role in the severity of RSV infections.
The findings suggest that bHB could be a therapeutic alternative to a ketogenic diet. The results also highlight the protective role of the gut microbiota and its metabolites in autoimmune…
The presence of specific microbes in the gut microbiota can serve as biomarkers for predicting the efficacy of immunotherapy.
By suggesting that the diversity and variety of microbial species play a big role in whether the transplanted microbes can successfully colonize a recipient’s gut, the findings could pave the…
